These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23140189)

  • 21. Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
    Li Q; Zhou M; Han L; Cao Q; Wang X; Zhao L; Zhou J; Zhang H
    Chem Biol Drug Des; 2015 Oct; 86(4):849-56. PubMed ID: 25787859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dipeptidyl-peptidase-4 inhibitors (gliptins): a new class of oral antidiabetic drugs].
    Jermendy G
    Orv Hetil; 2011 Sep; 152(37):1471-6. PubMed ID: 21893477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
    Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM
    Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
    Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
    J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A.
    Chakraborty C; Hsu MJ; Agoramoorthy G
    Cell Biochem Biophys; 2014 Nov; 70(2):907-22. PubMed ID: 24809328
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Sharma P; Joshi T; Mathpal S; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(21):10543-10560. PubMed ID: 34225570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors.
    Ran Y; Pei H; Shao M; Chen L
    Chem Biol Drug Des; 2016 Feb; 87(2):290-5. PubMed ID: 26426933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM; Mohammad MK; Taha MO
    ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors.
    Kumar S; Mittal A; Mittal A
    Bioorg Med Chem; 2021 Sep; 46():116354. PubMed ID: 34428715
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Sharma S; Srivastav S; Singh G; Singh S; Malik R; Alam MM; Shaqiquzamman M; Ali S; Akhter M
    J Biomol Struct Dyn; 2021 Apr; 39(6):2118-2132. PubMed ID: 32248758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach.
    Islam S; Amin MA; Rengasamy KRR; Mohiuddin AKM; Mahmud S
    Cancer Med; 2024 Aug; 13(15):e70074. PubMed ID: 39101505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.
    Savateev K; Fedotov V; Butorin I; Eltsov O; Slepukhin P; Ulomsky E; Rusinov V; Litvinov R; Babkov D; Khokhlacheva E; Radaev P; Vassiliev P; Spasov A
    Eur J Med Chem; 2020 Jan; 185():111808. PubMed ID: 31683103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
    Kaur M; Silakari O
    J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-Silico Screening of Ligand Based Pharmacophore, Database Mining and Molecular Docking on 2, 5-Diaminopyrimidines Azapurines as Potential Inhibitors of Glycogen Synthase Kinase-3β.
    Mishra P; Kesar S; Paliwal SK; Chauhan M; Madan K
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):150-158. PubMed ID: 29848281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.